Literature DB >> 8458152

Electromyographic analysis of the anterior cruciate ligament-deficient knee.

J E Tibone1, T J Antich.   

Abstract

The protective relationship of the human anterior cruciate ligament (ACL) by active contraction of the hamstring musculature has been known and understood by sports orthopedists and physical therapists for many years. Rehabilitation programs for patients with torn ACLs as well as those treated with ligament reconstruction have always stressed hamstring strengthening. Research in this area during the past decade has begun to define the proprioceptive mechanism that governs this relationship as well as the actual recording of dynamic muscle firing patterns in pre- and postoperative subjects. Laboratory studies suggest that altered hamstring activity may help these subjects compensate for a knee that is lax because of ACL damage.

Entities:  

Mesh:

Year:  1993        PMID: 8458152

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  4 in total

1.  Different knee joint loading patterns in ACL deficient copers and non-copers during walking.

Authors:  Tine Alkjær; Marius Henriksen; Erik B Simonsen
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2010-11-04       Impact factor: 4.342

2.  Muscle preactivity of anterior cruciate ligament-deficient and -reconstructed females during functional activities.

Authors:  R G Demont; S M Lephart; J L Giraldo; C B Swanik; F H Fu
Journal:  J Athl Train       Date:  1999-04       Impact factor: 2.860

3.  Study on three-dimensional kinematics and electromyography of ACL deficient knee participants wearing a functional knee brace during running.

Authors:  Daniel Théoret; Mario Lamontagne
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2006-04-06       Impact factor: 4.342

4.  Factors explaining chronic knee extensor strength deficits after ACL reconstruction.

Authors:  Chandramouli Krishnan; Glenn N Williams
Journal:  J Orthop Res       Date:  2011-01-18       Impact factor: 3.494

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.